DealBook: Trial Date Set for Former SAC Trader in Insider Case Federal prosecutors have accused Mathew Martoma of making more than $276 million in a combination of illegal profits and avoided losses trading in the shares of the pharmaceutical companies Elan and Wyeth.
June 5, 2013 - New York Times
Seth Waxman in The Miami Herald Wyeth could not change Phenergan's labeling to comply with Vermont law without violating federal law,argues Seth Waxman, who'll represent Wyeth before the Supreme Court.
John Paul Stevens in Reuters The question we must decide is whether the FDA's approvals provide Wyeth with a complete defense to Levine's tort claims. We conclude that they do not,Justice John Paul Stevens concluded in the court's majority opinion.